Clinical Trials Browser

Phase 1 × Malignant mesenchymal tumor × NHS-IL12 immunocytokine × Clear all

NCT01417546 2021-10-18

NHS-IL12 for Solid Tumors

Phase 1 Completed

Malignant mesenchymal tumor, Carcinoma